Ultrasound-guided radar reflector localization of axillary lymph nodes facilitates targeted axillary dissection

This study evaluated feasibility and patient outcomes for targeted axillary lymph node (LN) dissection (TAD) with SAVI SCOUT® ultrasound-guided radar reflector localization (RRL). In this IRB-approved retrospective study, 800 consecutive patients who underwent ultrasound-guided RRL between November...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical imaging 2022-10, Vol.90, p.19-25
Hauptverfasser: Weinfurtner, R. Jared, Leon, Amie, Calvert, Alexander, Lee, M. Catherine
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 25
container_issue
container_start_page 19
container_title Clinical imaging
container_volume 90
creator Weinfurtner, R. Jared
Leon, Amie
Calvert, Alexander
Lee, M. Catherine
description This study evaluated feasibility and patient outcomes for targeted axillary lymph node (LN) dissection (TAD) with SAVI SCOUT® ultrasound-guided radar reflector localization (RRL). In this IRB-approved retrospective study, 800 consecutive patients who underwent ultrasound-guided RRL between November 2017 and June 2020 were reviewed. Of these patients, those with axillary LN RRL were included in this study. Reports in the electronic medical record were reviewed to determine RRL placement, retrieval, and surgical outcomes. A total of 147 patients met inclusion criteria. Of these, axillary RRL was performed for biopsy-proven metastatic disease in 134 and inconclusive or benign biopsy in 13. RRL was successful in 146/151 lymph nodes (97%). Two patients had placement >10 mm from target and 3 had no post-placement signal. In all 5, the targets were successfully retrieved at surgery. Specimen radiographs were performed in 135 cases and confirmed the intended target in all 135 (100%). In 109 patients who underwent TAD + sentinel lymph node biopsy (SLNB), the RRL LN and the SLN(s) were different in 18 (17%). In 3 of these, the RRL LN was the only malignant LN (3%). In the 105 patients who underwent neoadjuvant chemotherapy, 43% (45/105) achieved nodal pCR and 85% (89/105) had
doi_str_mv 10.1016/j.clinimag.2022.07.007
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2697091464</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0899707122001851</els_id><sourcerecordid>2707863415</sourcerecordid><originalsourceid>FETCH-LOGICAL-c303t-76d7d4a4c29754b73d5eafc6f04df485cfa24ee771b299a25bbb1575b1db76cd3</originalsourceid><addsrcrecordid>eNqFkc1OxCAUhYnRxHH0FQyJGzetQGkpO83Ev8TEjbMmFOhIw5QRqHF8epmMunDj6t7Fd07uPQeAc4xKjHBzNZTK2dGu5aokiJASsRIhdgBmuGVVQSnnh2CGWs4Lhhg-BicxDigLOWUz4JcuBRn9NOpiNVltNAxSywCD6Z1RyQfovJLOfspk_Qh9D-WHdU6GLXTb9eYVjl6bCHuprLNJprwnGVYmZadfUtsYs1k2OAVHvXTRnH3POVje3b4sHoqn5_vHxc1ToSpUpYI1mmkqqSKc1bRjla6N7FXTI6p72taql4QawxjuCOeS1F3X4ZrVHdYda5Su5uBy77sJ_m0yMYm1jcrkc0bjpyhIwxnimDY0oxd_0MFPYczXCZITa5uK4jpTzZ5SwceY0xGbkDMPW4GR2PUgBvHTg9j1IBATuYcsvN4LTX733ZogorJmVEbbkDMR2tv_LL4Ajo2Xvg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2707863415</pqid></control><display><type>article</type><title>Ultrasound-guided radar reflector localization of axillary lymph nodes facilitates targeted axillary dissection</title><source>ScienceDirect Journals (5 years ago - present)</source><creator>Weinfurtner, R. Jared ; Leon, Amie ; Calvert, Alexander ; Lee, M. Catherine</creator><creatorcontrib>Weinfurtner, R. Jared ; Leon, Amie ; Calvert, Alexander ; Lee, M. Catherine</creatorcontrib><description>This study evaluated feasibility and patient outcomes for targeted axillary lymph node (LN) dissection (TAD) with SAVI SCOUT® ultrasound-guided radar reflector localization (RRL). In this IRB-approved retrospective study, 800 consecutive patients who underwent ultrasound-guided RRL between November 2017 and June 2020 were reviewed. Of these patients, those with axillary LN RRL were included in this study. Reports in the electronic medical record were reviewed to determine RRL placement, retrieval, and surgical outcomes. A total of 147 patients met inclusion criteria. Of these, axillary RRL was performed for biopsy-proven metastatic disease in 134 and inconclusive or benign biopsy in 13. RRL was successful in 146/151 lymph nodes (97%). Two patients had placement &gt;10 mm from target and 3 had no post-placement signal. In all 5, the targets were successfully retrieved at surgery. Specimen radiographs were performed in 135 cases and confirmed the intended target in all 135 (100%). In 109 patients who underwent TAD + sentinel lymph node biopsy (SLNB), the RRL LN and the SLN(s) were different in 18 (17%). In 3 of these, the RRL LN was the only malignant LN (3%). In the 105 patients who underwent neoadjuvant chemotherapy, 43% (45/105) achieved nodal pCR and 85% (89/105) had &lt;3 metastatic lymph nodes at surgery. Ultrasound-guided RRL of axillary LNs is a feasible approach to facilitate TAD with high placement and retrieval success rates. This enables TAD as an alternative to complete axillary LN dissection (cALND), sparing some patients with low nodal tumor burden from cALND. •US-guided SAVI SCOUT® radar reflector localization of axillary lymph nodes is highly successful (97% initial placement success rate, 100% surgery retrieval success rate)•This facilitates targeted axillary dissection + sentinel lymph node biopsy in patients with high likelihood of achieving low nodal burden•For ER/PR+ patients with only 1 suspicious lymph node on initial imaging, 95% had low nodal burden after neoadjuvant chemotherapy Precis•US-guided SAVI SCOUT® radar reflector localization of axillary lymph nodes is highly successful and facilitates targeted axillary dissection in patients with a likelihood of low axillary nodal burden</description><identifier>ISSN: 0899-7071</identifier><identifier>EISSN: 1873-4499</identifier><identifier>DOI: 10.1016/j.clinimag.2022.07.007</identifier><language>eng</language><publisher>Philadelphia: Elsevier Inc</publisher><subject>Axillary lymph nodes ; Biopsy ; Breast cancer ; Cancer therapies ; Chemotherapy ; Dissection ; Documentation ; Electronic health records ; Electronic medical records ; Feasibility studies ; Localization ; Lymph nodes ; Lymphatic system ; Mammography ; Metastases ; Metastasis ; Pathology ; Patients ; Radar ; Radar reflector localization ; Radar reflectors ; Retrieval ; Surgeons ; Surgery ; Surgical outcomes ; Targeted axillary dissection ; Tumors ; Ultrasonic imaging ; Ultrasound</subject><ispartof>Clinical imaging, 2022-10, Vol.90, p.19-25</ispartof><rights>2022 Elsevier Inc.</rights><rights>2022. Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c303t-76d7d4a4c29754b73d5eafc6f04df485cfa24ee771b299a25bbb1575b1db76cd3</citedby><cites>FETCH-LOGICAL-c303t-76d7d4a4c29754b73d5eafc6f04df485cfa24ee771b299a25bbb1575b1db76cd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.clinimag.2022.07.007$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids></links><search><creatorcontrib>Weinfurtner, R. Jared</creatorcontrib><creatorcontrib>Leon, Amie</creatorcontrib><creatorcontrib>Calvert, Alexander</creatorcontrib><creatorcontrib>Lee, M. Catherine</creatorcontrib><title>Ultrasound-guided radar reflector localization of axillary lymph nodes facilitates targeted axillary dissection</title><title>Clinical imaging</title><description>This study evaluated feasibility and patient outcomes for targeted axillary lymph node (LN) dissection (TAD) with SAVI SCOUT® ultrasound-guided radar reflector localization (RRL). In this IRB-approved retrospective study, 800 consecutive patients who underwent ultrasound-guided RRL between November 2017 and June 2020 were reviewed. Of these patients, those with axillary LN RRL were included in this study. Reports in the electronic medical record were reviewed to determine RRL placement, retrieval, and surgical outcomes. A total of 147 patients met inclusion criteria. Of these, axillary RRL was performed for biopsy-proven metastatic disease in 134 and inconclusive or benign biopsy in 13. RRL was successful in 146/151 lymph nodes (97%). Two patients had placement &gt;10 mm from target and 3 had no post-placement signal. In all 5, the targets were successfully retrieved at surgery. Specimen radiographs were performed in 135 cases and confirmed the intended target in all 135 (100%). In 109 patients who underwent TAD + sentinel lymph node biopsy (SLNB), the RRL LN and the SLN(s) were different in 18 (17%). In 3 of these, the RRL LN was the only malignant LN (3%). In the 105 patients who underwent neoadjuvant chemotherapy, 43% (45/105) achieved nodal pCR and 85% (89/105) had &lt;3 metastatic lymph nodes at surgery. Ultrasound-guided RRL of axillary LNs is a feasible approach to facilitate TAD with high placement and retrieval success rates. This enables TAD as an alternative to complete axillary LN dissection (cALND), sparing some patients with low nodal tumor burden from cALND. •US-guided SAVI SCOUT® radar reflector localization of axillary lymph nodes is highly successful (97% initial placement success rate, 100% surgery retrieval success rate)•This facilitates targeted axillary dissection + sentinel lymph node biopsy in patients with high likelihood of achieving low nodal burden•For ER/PR+ patients with only 1 suspicious lymph node on initial imaging, 95% had low nodal burden after neoadjuvant chemotherapy Precis•US-guided SAVI SCOUT® radar reflector localization of axillary lymph nodes is highly successful and facilitates targeted axillary dissection in patients with a likelihood of low axillary nodal burden</description><subject>Axillary lymph nodes</subject><subject>Biopsy</subject><subject>Breast cancer</subject><subject>Cancer therapies</subject><subject>Chemotherapy</subject><subject>Dissection</subject><subject>Documentation</subject><subject>Electronic health records</subject><subject>Electronic medical records</subject><subject>Feasibility studies</subject><subject>Localization</subject><subject>Lymph nodes</subject><subject>Lymphatic system</subject><subject>Mammography</subject><subject>Metastases</subject><subject>Metastasis</subject><subject>Pathology</subject><subject>Patients</subject><subject>Radar</subject><subject>Radar reflector localization</subject><subject>Radar reflectors</subject><subject>Retrieval</subject><subject>Surgeons</subject><subject>Surgery</subject><subject>Surgical outcomes</subject><subject>Targeted axillary dissection</subject><subject>Tumors</subject><subject>Ultrasonic imaging</subject><subject>Ultrasound</subject><issn>0899-7071</issn><issn>1873-4499</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqFkc1OxCAUhYnRxHH0FQyJGzetQGkpO83Ev8TEjbMmFOhIw5QRqHF8epmMunDj6t7Fd07uPQeAc4xKjHBzNZTK2dGu5aokiJASsRIhdgBmuGVVQSnnh2CGWs4Lhhg-BicxDigLOWUz4JcuBRn9NOpiNVltNAxSywCD6Z1RyQfovJLOfspk_Qh9D-WHdU6GLXTb9eYVjl6bCHuprLNJprwnGVYmZadfUtsYs1k2OAVHvXTRnH3POVje3b4sHoqn5_vHxc1ToSpUpYI1mmkqqSKc1bRjla6N7FXTI6p72taql4QawxjuCOeS1F3X4ZrVHdYda5Su5uBy77sJ_m0yMYm1jcrkc0bjpyhIwxnimDY0oxd_0MFPYczXCZITa5uK4jpTzZ5SwceY0xGbkDMPW4GR2PUgBvHTg9j1IBATuYcsvN4LTX733ZogorJmVEbbkDMR2tv_LL4Ajo2Xvg</recordid><startdate>202210</startdate><enddate>202210</enddate><creator>Weinfurtner, R. Jared</creator><creator>Leon, Amie</creator><creator>Calvert, Alexander</creator><creator>Lee, M. Catherine</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7Z</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>202210</creationdate><title>Ultrasound-guided radar reflector localization of axillary lymph nodes facilitates targeted axillary dissection</title><author>Weinfurtner, R. Jared ; Leon, Amie ; Calvert, Alexander ; Lee, M. Catherine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c303t-76d7d4a4c29754b73d5eafc6f04df485cfa24ee771b299a25bbb1575b1db76cd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Axillary lymph nodes</topic><topic>Biopsy</topic><topic>Breast cancer</topic><topic>Cancer therapies</topic><topic>Chemotherapy</topic><topic>Dissection</topic><topic>Documentation</topic><topic>Electronic health records</topic><topic>Electronic medical records</topic><topic>Feasibility studies</topic><topic>Localization</topic><topic>Lymph nodes</topic><topic>Lymphatic system</topic><topic>Mammography</topic><topic>Metastases</topic><topic>Metastasis</topic><topic>Pathology</topic><topic>Patients</topic><topic>Radar</topic><topic>Radar reflector localization</topic><topic>Radar reflectors</topic><topic>Retrieval</topic><topic>Surgeons</topic><topic>Surgery</topic><topic>Surgical outcomes</topic><topic>Targeted axillary dissection</topic><topic>Tumors</topic><topic>Ultrasonic imaging</topic><topic>Ultrasound</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Weinfurtner, R. Jared</creatorcontrib><creatorcontrib>Leon, Amie</creatorcontrib><creatorcontrib>Calvert, Alexander</creatorcontrib><creatorcontrib>Lee, M. Catherine</creatorcontrib><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Weinfurtner, R. Jared</au><au>Leon, Amie</au><au>Calvert, Alexander</au><au>Lee, M. Catherine</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ultrasound-guided radar reflector localization of axillary lymph nodes facilitates targeted axillary dissection</atitle><jtitle>Clinical imaging</jtitle><date>2022-10</date><risdate>2022</risdate><volume>90</volume><spage>19</spage><epage>25</epage><pages>19-25</pages><issn>0899-7071</issn><eissn>1873-4499</eissn><abstract>This study evaluated feasibility and patient outcomes for targeted axillary lymph node (LN) dissection (TAD) with SAVI SCOUT® ultrasound-guided radar reflector localization (RRL). In this IRB-approved retrospective study, 800 consecutive patients who underwent ultrasound-guided RRL between November 2017 and June 2020 were reviewed. Of these patients, those with axillary LN RRL were included in this study. Reports in the electronic medical record were reviewed to determine RRL placement, retrieval, and surgical outcomes. A total of 147 patients met inclusion criteria. Of these, axillary RRL was performed for biopsy-proven metastatic disease in 134 and inconclusive or benign biopsy in 13. RRL was successful in 146/151 lymph nodes (97%). Two patients had placement &gt;10 mm from target and 3 had no post-placement signal. In all 5, the targets were successfully retrieved at surgery. Specimen radiographs were performed in 135 cases and confirmed the intended target in all 135 (100%). In 109 patients who underwent TAD + sentinel lymph node biopsy (SLNB), the RRL LN and the SLN(s) were different in 18 (17%). In 3 of these, the RRL LN was the only malignant LN (3%). In the 105 patients who underwent neoadjuvant chemotherapy, 43% (45/105) achieved nodal pCR and 85% (89/105) had &lt;3 metastatic lymph nodes at surgery. Ultrasound-guided RRL of axillary LNs is a feasible approach to facilitate TAD with high placement and retrieval success rates. This enables TAD as an alternative to complete axillary LN dissection (cALND), sparing some patients with low nodal tumor burden from cALND. •US-guided SAVI SCOUT® radar reflector localization of axillary lymph nodes is highly successful (97% initial placement success rate, 100% surgery retrieval success rate)•This facilitates targeted axillary dissection + sentinel lymph node biopsy in patients with high likelihood of achieving low nodal burden•For ER/PR+ patients with only 1 suspicious lymph node on initial imaging, 95% had low nodal burden after neoadjuvant chemotherapy Precis•US-guided SAVI SCOUT® radar reflector localization of axillary lymph nodes is highly successful and facilitates targeted axillary dissection in patients with a likelihood of low axillary nodal burden</abstract><cop>Philadelphia</cop><pub>Elsevier Inc</pub><doi>10.1016/j.clinimag.2022.07.007</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0899-7071
ispartof Clinical imaging, 2022-10, Vol.90, p.19-25
issn 0899-7071
1873-4499
language eng
recordid cdi_proquest_miscellaneous_2697091464
source ScienceDirect Journals (5 years ago - present)
subjects Axillary lymph nodes
Biopsy
Breast cancer
Cancer therapies
Chemotherapy
Dissection
Documentation
Electronic health records
Electronic medical records
Feasibility studies
Localization
Lymph nodes
Lymphatic system
Mammography
Metastases
Metastasis
Pathology
Patients
Radar
Radar reflector localization
Radar reflectors
Retrieval
Surgeons
Surgery
Surgical outcomes
Targeted axillary dissection
Tumors
Ultrasonic imaging
Ultrasound
title Ultrasound-guided radar reflector localization of axillary lymph nodes facilitates targeted axillary dissection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T23%3A18%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ultrasound-guided%20radar%20reflector%20localization%20of%20axillary%20lymph%20nodes%20facilitates%20targeted%20axillary%20dissection&rft.jtitle=Clinical%20imaging&rft.au=Weinfurtner,%20R.%20Jared&rft.date=2022-10&rft.volume=90&rft.spage=19&rft.epage=25&rft.pages=19-25&rft.issn=0899-7071&rft.eissn=1873-4499&rft_id=info:doi/10.1016/j.clinimag.2022.07.007&rft_dat=%3Cproquest_cross%3E2707863415%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2707863415&rft_id=info:pmid/&rft_els_id=S0899707122001851&rfr_iscdi=true